CY2597B2 - Fusion glycoprotein from HCMV and HSV - Google Patents

Fusion glycoprotein from HCMV and HSV

Info

Publication number
CY2597B2
CY2597B2 CY0600028A CY0600028A CY2597B2 CY 2597 B2 CY2597 B2 CY 2597B2 CY 0600028 A CY0600028 A CY 0600028A CY 0600028 A CY0600028 A CY 0600028A CY 2597 B2 CY2597 B2 CY 2597B2
Authority
CY
Cyprus
Prior art keywords
hsv
hcmv
fusion glycoprotein
glycoprotein
fusion
Prior art date
Application number
CY0600028A
Other languages
English (en)
Inventor
Dirk R Gheysen
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of CY2597B2 publication Critical patent/CY2597B2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/035—Herpes simplex virus I or II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY0600028A 1994-05-18 2006-10-16 Fusion glycoprotein from HCMV and HSV CY2597B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409962A GB9409962D0 (en) 1994-05-18 1994-05-18 Novel compounds

Publications (1)

Publication Number Publication Date
CY2597B2 true CY2597B2 (en) 2010-03-03

Family

ID=10755348

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0600028A CY2597B2 (en) 1994-05-18 2006-10-16 Fusion glycoprotein from HCMV and HSV

Country Status (20)

Country Link
US (3) US5889168A (de)
EP (2) EP0759995B1 (de)
JP (1) JPH10500009A (de)
KR (1) KR970703428A (de)
AT (2) ATE293697T1 (de)
AU (1) AU2527195A (de)
BR (1) BR9507728A (de)
CA (1) CA2190529A1 (de)
CY (1) CY2597B2 (de)
DE (2) DE69534162T2 (de)
DK (1) DK0759995T3 (de)
ES (2) ES2239758T3 (de)
GB (1) GB9409962D0 (de)
HU (1) HU9603163D0 (de)
NO (1) NO964874D0 (de)
PL (1) PL317235A1 (de)
PT (1) PT759995E (de)
SI (1) SI0759995T1 (de)
WO (1) WO1995031555A1 (de)
ZA (1) ZA953961B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409962D0 (en) * 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds
TR200002608T2 (tr) * 1998-03-09 2000-11-21 Smithkline Beecham Biologicals S.A Kombine aşı kompozisyonları
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
AU2005299923A1 (en) * 2004-10-22 2006-05-04 Cargill, Incorporated Process for the production of maltodextrins and maltodextrins
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101652060B1 (ko) * 2008-12-25 2016-08-29 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 재조합 닭 전염성 코라이자 백신 및 그 제조방법
EP2493911B1 (de) * 2009-10-30 2017-10-18 The Administrators of The Tulane Educational Fund Peptidzusammensetzungen und verfahren zur hemmung von herpesvirusinfektionen
TW201305190A (zh) 2010-10-15 2013-02-01 Glaxosmithkline Biolog Sa 新穎之抗原
WO2015047901A1 (en) * 2013-09-24 2015-04-02 Duke University Compositions, methods and kits for eliciting an immune response
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
EP0289550B1 (de) * 1986-10-20 1996-04-10 Chiron Corporation Impfstoff zur behandlung von hsv
JP2607712B2 (ja) * 1988-01-29 1997-05-07 カイロン コーポレイション 組換えｃｍｖ中和タンパク
GB9409962D0 (en) * 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
DE69534162T2 (de) 2006-03-09
BR9507728A (pt) 1997-09-23
EP0759995B1 (de) 2005-04-20
DE69534162D1 (de) 2005-05-25
ES2353134T3 (es) 2011-02-25
EP1529845A2 (de) 2005-05-11
HU9603163D0 (en) 1997-01-28
ZA953961B (en) 1996-02-26
NO964874L (no) 1996-11-15
WO1995031555A1 (en) 1995-11-23
US5739292A (en) 1998-04-14
KR970703428A (ko) 1997-07-03
GB9409962D0 (en) 1994-07-06
DK0759995T3 (da) 2005-08-01
PL317235A1 (en) 1997-03-17
DE69536112D1 (de) 2010-11-18
CA2190529A1 (en) 1995-11-23
EP0759995A1 (de) 1997-03-05
SI0759995T1 (en) 2005-10-31
ATE483809T1 (de) 2010-10-15
NO964874D0 (no) 1996-11-15
ATE293697T1 (de) 2005-05-15
PT759995E (pt) 2005-07-29
HK1012415A1 (en) 1999-07-30
AU2527195A (en) 1995-12-05
JPH10500009A (ja) 1998-01-06
US6036959A (en) 2000-03-14
ES2239758T3 (es) 2005-10-01
EP1529845B1 (de) 2010-10-06
EP1529845A3 (de) 2006-03-08
US5889168A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
PL317235A1 (en) Fusion glycoprotein from hcmv and hsv
EP0785276A4 (de) Modifizierung eines peptids und eines proteins
PL320824A1 (en) Aerodol form of a preparation of peptides and proteins
ZA932362B (en) Cloning expression and uses of a novel secreted protein F-spondin
EP0704532A3 (de) Rekombinante Chimäre Proteine und Verfahren zur deren Verwendung
AU3241095A (en) Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
EP0644931A4 (de) Rekombinantes truthahn-herpesvirus und seine verwendung.
EP0222366A3 (en) Human lysozyme
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
EP0565626A4 (en) Fusions of a viral protein and a destructive enzyme
EP0747482A3 (de) Rekombinante Proteine des Hepatitis GB Virus ihre Verwendungen
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
IL116973A0 (en) Extraction of recombinant proteins
AU2497095A (en) Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
EP0669933A4 (de) Reinigung von fusionsproteinen, die gm-csf und il-3 enthalten.
ZA946887B (en) Novel proteins/polypeptides and cotransfection plasmics and live recombinant carriers therefor
NO944025D0 (no) Forbedret fremstilling av rekombinant protein
AU3952895A (en) Stable recombinant hcmv protease
GB9204180D0 (en) Purification of recombinant proteins
AUPM421994A0 (en) A system for expression of recombinant proteins
GB8828726D0 (en) Purification of recombinant protein
ZA938572B (en) Improved recombinant protein production
GB9107472D0 (en) Method of producing recombinant viruses using linearised viral dna and vectors therefor
IL113225A0 (en) Method of protein and peptide cleavage